학술논문
Immunogenicity, safety, and preliminary efficacy evaluation of OVX836, a nucleoprotein-based universal influenza A vaccine candidate: a randomised, double-blind, placebo-controlled, phase 2a trial
Document Type
Article
Author
Source
In The Lancet Infectious Diseases December 2023 23(12):1360-1369
Subject
Language
ISSN
1473-3099